European Regulators Back First Gene Therapy Drug
European regulators back first gene therapy drug
Filed under: drug treatment news stories
LONDON (Reuters) – European regulators have recommended approval of the Western world's first gene therapy drug — after rejecting it on three previous occasions — in a significant advance for the novel medical technology. More than 20 … UniQure's …
Read more on Chicago Tribune
FDA recommends drug to treat diabetics' vision loss
Filed under: drug treatment news stories
Print; Font: +; -. A U.S. Food and Drug Administration panel on Thursday recommended Roche Holding AG's Lucentis eye drug for treatment of diabetic macular edema, a leading cause of vision loss among working-age people. Don't miss these Health stories …
Read more on msnbc.com
European regulators approves Novartis drug Afinitor to treat women with …
Filed under: drug treatment news stories
GENEVA — Swiss drug maker Novartis AG says it has received European approval to market Afinitor for treatment of women with the most common form of advanced breast cancer. … In some cases, contributors are sources or experts quoted in a story.
Read more on Washington Post
FDA approves new drug to treat blood cancer
Filed under: drug treatment news stories
Next story in Cancer FDA approves Afinitor for some breast cancers. related. Advertise | AdChoices. By Anna Yukhananov. updated 7/20/2012 4:15:17 PM ET … The U.S. Food and Drug Administration said on Friday the intravenous drug was approved for …
Read more on msnbc.com
More drug treatment news stories Resources
WISTA OCTOBER 2003The leading European provider of transgenic cellular and animal models, genOway have succeeded in as to reach the market with its first drug application by reconstitution in gene therapy. The issuance of these new … Doc Viewer
2011 In ReflectionThe European Medicines Agency rejected AMT Therapeutics’ alipogene tiparvovec, providing yet another setback for gene therapy. more on-time first-cycle approvals. Other key changes in PDUFA V include more meetings between regulators and drug developers to … Doc Viewer
ISPOR Personalized Medicine Special Interest GroupSingle gene or biomarker tests Periodic treatment reassessment Oncotype Dx + adjuvant breast cancer therapy • Test co-developed with the drug –E.g., Warfarin back on the envelope calculation: • Drug cheap, adverse event costs high … Access Document
Superbugs On The Hoof?The European Union has issued new rules limiting the use of several They contend that regulators and pub-lic health activists are blowing the problem First, microbial sleuths must link a livestock antibiotic to a drug:1esit*, strain. … Read Full Source
Www.neuroscience.utoronto.ca – NEUROSCIENCE NEWSLETTER …FIRST CLINICAL TRIAL OF HUMAN EMBRYONIC STEM CELL THERAPY IN THE WORLD BEGINS GLAXOSMITHKLINE, VALEANT'S EPILEPSY DRUG TROBALT APPROVED IN EUROPE. GlaxoSmithKline and Valeant Pharmaceuticals announced Tuesday that European regulators approved Trobalt … Get Doc
WITH Jean Marimbert Director GeneralTo enter a drug into the market. Can you explain to our readers the main cosmetics, gene therapy, etc. The agency has a rather wide scope but first European directive which dates back to 1965 was free market in nature … View Doc
Personalized Medicine: The Pharmacogenomic Approach To …One of the first companies to travel down this road was Amgen. Vectibix, an antiEGFR monoclonal ab, received a thumbs down from european regulators in 2007 given related to common disorders and drug therapy UKGTN has primarily addressed tests for single gene of known SNPs is reported back … Fetch Doc
Angiogenesis ResearchThe first known inducer of angio genesis (new blood vessel forma patients undergoing standard drug therapy for rheum If you could go back in time, peer into a crystal ball and see … Fetch Document
Transgenics Finally Gets First Regulatory OKBeginning back in the mid ’80s, a group of First Regulatory OK BY JOHN CARROLL Goats genetically altered with a human gene could become low-cost factories for producing new drug therapies. regulators that they had a work-ing therapy. The EMEA turned … Retrieve Content
Small Rho GTPases And Cholesterol Biosynthetic Pathway …Present address: Division of Gene Therapy, School of Medicine, Center for Applied 95 Here we explored, for the first time, the relevance of Rho GTPase subfamily These are key regulators of the cell cytoskeleton, cell cycle, gene expression and … Read Document
The Future Of TB Diagnostic Clinical Research: From Silos To …(latent and active) ?Rapidly identify drug resistance to both first– and In development until aborted in 12/10 when the European crucial for advancing TB therapy and drug/combo discovery and development ?Detect markers for dormant state or gene … View Full Source
RMS LifeRisks Monitor: February 2012The next wave of mortality improvement in European countries will Abiraterone passed the first three hurdles (safety, efficacy, and quality) with drug regulators in the U.S. and Europe. Through a combination of genetic engineering and drug therapy … Fetch Here
… Retrieve Full SourceReports, which have covered important areas in biotechnology, gene therapy testing for rare diseases now faces the same plight that held back drugs for rare diseases from the marketplace before the Orphan Drug aid the screening of drug responders, drug safety and improve drug efficacy. The European … Retrieve Document
I-baseregulators, and public health authorities agree on re-infused back into the individual. The ultimate goal is to combine the CD4 and CD8 T cell gene therapy approaches in order to bolster by researchers developing M87o, a gene therapy that encodes an HIV entry inhibitor similar to the drug Fuzeon … Read Full Source
Abstract Of British Medical JournalChild in gene therapy programme develops leukaemia. are developing a new code of marketing that will, for the first Effect of European Clinical Trials Direc tive on academic drug trials in Denmark: retro … Get Content Here
Www.chlassoc.comSome technology platforms were back in fashion, especially where pharma needed an R&D been published in several respected scientific journals, including Science, Human Gene Therapy is a significant setback for Novartis, which has avidly sought an approval of the drug. European regulators are … View This Document